GANX
NASDAQ
$1.84
Gain Therapeutics Inc (GANX)
Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $7.20 (+291.30%)
Market Cap
$71M
FCF 5Y CAGR
+29.39%
Free Cash Flow Yield
-27.14%
Beta (5Y)
1.35
Price Chart
Valuation
Market Cap$71M
P/S255.50
P/B5.13
Profitability
Gross Profit (TTM)-$11M
EBITDA-$20M
EPS-$0.58
Financial Health
Debt-to-Equity2.7%
Free Cash Flow Yield-27.14%
Growth & Risk
EPS 5Y CAGR-8.92%
FCF 5Y CAGR+29.39%
Beta (5Y)1.35
Sharpe Ratio0.54